Our long-term goal is to understand the mechanisms regulating transcription of NF?B-dependent anti-apoptotic and pro-inflammatory genes. Since NF?B activity and expression of NF?B-regulated pro-inflammatory and anti-apoptotic genes are increased in many inflammatory diseases, as well as in many types of human cancer and leukemia, inhibition of NF?B-dependent transcription thus represents an important therapeutic target. However, one of the main concerns regarding the NF?B inhibitors is their specificity, since many steps leading to NF?B activation are important for other cellular functions as well. Our previous studies have shown that an induction of nuclear translocation and accumulation of the NF?B inhibitor, I?B?, inhibits the in vitro NF?B DNA binding activity and induces apoptosis in human leukocytes and cancer cells. Importantly, our recent data indicate that the in vivo inhibition of NF?B-dependent transcription by nuclear I?B? is gene specific: while the transcription of pro-inflammatory cytokines TNF?, IL-12 and IL-6 in human leukocytes is inhibited by nuclear I?B?, transcription of IL-8 is not. However, at present, the mechanisms that regulate the in vivo nuclear interaction of I?B? with NF?B proteins and NF?B- dependent promoters are unknown. The central hypothesis of this proposal is that the regulation of NF?B-dependent transcription of pro-inflammatory and anti-apoptotic genes by nuclear I?B? is gene specific, and could thus provide a basis for novel anti-inflammatory and anti-cancer therapies aimed at the specific inhibition of NF?B activity by nuclear I?B?.
The specific aims focus on analyzing the mechanisms that regulate the in vivo binding of I?B? to NF?B dimers and NF?B promoters, thus regulating NF?B-dependent transcription.
In Aim 1, we will measure by chromatin immunoprecipitation the recruitment of NF?B and I?B? proteins to NF?B-regulated promoters of pro-inflammatory and anti-apoptotic genes in human U937 macrophages and leukemia Hut-78 cells. We will determine whether the ability of nuclear I?B? to inhibit NF?B-dependent transcription depends on the subunit composition of NF?B dimers.
In Aim 2, we will identify the mechanisms that regulate the nuclear I?B?-NF?B interaction in U937 macrophages and Hut-78 leukemia cells, and we will test the hypothesis that the responsible mechanisms involve post-translational modification(s) of p65 NF?B, and/or gene specific recruitment of the proteasome. Identification of the mechanisms that regulate the gene specific transcription of NF?B-dependent genes by nuclear I?B? might provide a new strategy that would use the nuclear I?B? as a specific regulator of NF?B-dependent transcription. This approach could be applicable in both anti-inflammatory and anti-cancer therapies. In addition, this project will enhance the research environment at St. John's University by providing undergraduate students with numerous opportunities to learn the fundamentals of biomedical research.

Public Health Relevance

This proposal focuses on the mechanisms that regulate ability of the nuclear inhibitory protein I?B? to associate with NF?B-regulated promoters and inhibit transcription of NF?B-dependent inflammatory and pro-survival genes. Since NF?B activity is increased in many human diseases including inflammatory disorders, cancer, and leukemia, identification of the mechanisms by which the nuclear I?B? inhibits NF?B-dependent transcription will lead to the development of more specific anti-inflammatory and anti-cancer therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15AI085497-01
Application #
7778063
Study Section
Special Emphasis Panel (ZRG1-F07-K (20))
Program Officer
Prograis, Lawrence J
Project Start
2010-03-01
Project End
2013-02-28
Budget Start
2010-03-01
Budget End
2013-02-28
Support Year
1
Fiscal Year
2010
Total Cost
$245,250
Indirect Cost
Name
St. John's University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
073134744
City
Queens
State
NY
Country
United States
Zip Code
11439
Chang, Tzu-Pei; Poltoratsky, Vladimir; Vancurova, Ivana (2015) Bortezomib inhibits expression of TGF-?1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells. J Immunol 194:2942-53
Kasat, K; Patel, H; Predtechenska, O et al. (2014) Anti-inflammatory actions of endogenous and exogenous interleukin-10 versus glucocorticoids on macrophage functions of the newly born. J Perinatol 34:380-5
Chang, Tzu-Pei; Vancurova, Ivana (2014) Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma. Biochim Biophys Acta 1843:2620-30
Singha, Bipradeb; Gatla, Himavanth Reddy; Manna, Subrata et al. (2014) Proteasome inhibition increases recruitment of I?B kinase ? (IKK?), S536P-p65, and transcription factor EGR1 to interleukin-8 (IL-8) promoter, resulting in increased IL-8 production in ovarian cancer cells. J Biol Chem 289:2687-700
Manna, Subrata; Singha, Bipradeb; Phyo, Sai Aung et al. (2013) Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKK?. J Immunol 191:2837-46
Chang, Tzu-Pei; Vancurova, Ivana (2013) NF?B function and regulation in cutaneous T-cell lymphoma. Am J Cancer Res 3:433-45
Ramaswami, Sitharam; Manna, Subrata; Juvekar, Ashish et al. (2012) Chromatin immunoprecipitation analysis of NFýýB transcriptional regulation by nuclear IýýBýý in human macrophages. Methods Mol Biol 809:121-34
Vancurova, Ivana; Vancura, Ales (2012) Regulation and function of nuclear I?B? in inflammation and cancer. Am J Clin Exp Immunol 1:56-66
Juvekar, Ashish; Ramaswami, Sitharam; Manna, Subrata et al. (2012) Electrophoretic mobility shift assay analysis of NFýýB transcriptional regulation by nuclear IýýBýý. Methods Mol Biol 809:49-62
Juvekar, Ashish; Manna, Subrata; Ramaswami, Sitharam et al. (2011) Bortezomib induces nuclear translocation of I?B? resulting in gene-specific suppression of NF-?B--dependent transcription and induction of apoptosis in CTCL. Mol Cancer Res 9:183-94

Showing the most recent 10 out of 11 publications